SecBot SecBot

PLSM

Pulsenmore Ltd.
Nasdaq· Surgical & Medical Instruments & Apparatus· CIK 0002064764 Healthcare & Medical Devices
$1.83 +0.06 (+3.33%)
Oct 26 4:00 PM ET · prev $1.77
Market cap
$11.5M
Nano cap
Since first trade
−75.1%
from $7.36 · Jan 21
30 days
−19.6%
from $2.28
Range since listing
$1.76–7.36
−75% from high · low Oct 20
Avg volume 20D
31.6K
shares / day
Short interest
7.7K
≈0.1% of shares · −63.5%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
13
analyzed by SecBot
SecBot read MIXED 8 reports · 90 days
Balance 1 bearish · 1 bullish · 1 mixed · 5 neutral oldest → newest, height = score
Avg score ·High conf. 2/8

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 0 trimmed or exited.

  • Short sellersCOVERING

    Short interest −63.5% to 7.7K shares. 1.0 days to cover, ≈0.1% of shares.

  • TrendDOWNTREND

    21% below its 50-day average. New closing low $1.76 on Oct 20.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGDOUBLED21,019$111.6K

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 31, 2026
Company news
Pulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026
Management to Host Webcast today at 8:30 am ET to discuss Results and Provide Business Update OMER, Israel, Aug. 31, 2026 /PRNewswire/ -- Pulsenmore…
Aug 24, 2026
Company news
Pulsenmore Ltd. To Announce Financial Results and Business Highlights and Hold Conference Call for the First Half of 2026
OMER, Israel, Aug. 24, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a leading innovator in remote maternal-fetal healthcare and…
Jul 13, 2026
Press release
Pulsenmore Selected for Israel Innovation Authority and Ministry of Health Program to Lead an $1 Million AI Development Project
The program is designed to enable Pulsenmore to develop and clinically validate AI applications that improve clinical workflow efficiency and…

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Oct 19, 2026
Woods David
Chief Commercial Officer
AWARD6,886 sh
Oct 14, 2026
Guz-Lavi Racheli
Director
EXERCISE$1.5K

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
7,733
shares short
-63.5%
vs prior settlement
1.0
days to cover
≈0.1%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 19, 2026 Insider
Woods David was granted 6,886 shares
Chief Commercial Officer
Oct 14, 2026 Insider
Guz-Lavi Racheli acquired via exercise 46,874 shares
Director @ $0.0320 ($1.5K)
Oct 13, 2026 SEC
Pulsenmore appointed med-tech veteran David Woods as Chief Commercial Officer and expanded its U.S. commercial team…
6-K — Impact 3/10
Oct 8, 2026 SEC
Analysis based on filing metadata only — document content was unavailable. A Schedule 13G was filed for Pulsenmore…
SC 13G — Impact 3/10
Sep 17, 2026 SEC
Pulsenmore announced MHRA registration for its Pulsenmore FC home ultrasound system, enabling marketing in the UK for…
6-K — Impact 4/10
Aug 31, 2026 Routine
Pulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026
Management to Host Webcast today at 8:30 am ET to discuss Results and Provide Business Update OMER,
Jun 30, 2026 Inst.
UBS Group AG — DOUBLED
21,019 shares ($111.6K)

SecBot reports

13 filings · 1 bullish · 2 bearish · 1 mixed · 9 neutral
All PLSM filing & press-release reports (13)